This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Loehberg, C. R. Articles by O'Malley, B. W. Search for Related Content PubMed PubMed Citation Articles by Loehberg, C. R. Articles by O'Malley, B. W. Related Collections Preclinical Intervention Preclinical Intervention: In Vitro: Drugs, Mechanisms

Ataxia Telangiectasia-Mutated and p53 Are Potential Mediators of Chloroquine-Induced Resistance to Mammary Carcinogenesis

¹ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas; ² Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee; and ³ Department of Obstetrics and Gynecology, University of Erlangen, Erlangen, Germany

Requests for reprints: Bert W. O'Malley, Department of Cellular and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: 713-798-6205; Fax: 713-798-5599; E-mail: berto{at}bcm.edu.

The use of agents to prevent the onset of and/or the progression to breast cancer has the potential to lower breast cancer risk. We have previously shown that the tumor-suppressor gene p53 is a potential mediator of hormone (estrogen/progesterone)-induced protection against chemical carcinogen–induced mammary carcinogenesis in animal models. Here, we show for the first time a breast cancer–protective effect of chloroquine in an animal model. Chloroquine significantly reduced the incidence of N-methyl-N-nitrosourea–induced mammary tumors in our animal model similar to estrogen/progesterone treatment. No protection was seen in our BALB/c p53-null mammary epithelium model, indicating a p53 dependency for the chloroquine effect. Using a human nontumorigenic mammary gland epithelial cell line, MCF10A, we confirm that in the absence of detectable DNA damage, chloroquine activates the tumor-suppressor p53 and the p53 downstream target gene p21, resulting in G₁ cell cycle arrest. p53 activation occurs at a posttranslational level via chloroquine-dependent phosphorylation of the checkpoint protein kinase, ataxia telangiectasia-mutated (ATM), leading to ATM-dependent phosphorylation of p53. In primary mammary gland epithelial cells isolated from p53-null mice, chloroquine does not induce G₁ cell cycle arrest compared with cells isolated from wild-type mice, also indicating a p53 dependency. Our results indicate that a short prior exposure to chloroquine may have a preventative application for mammary carcinogenesis. [Cancer Res 2007;67(24):12026–33]

This article has been cited by other articles:

				P. Concannon, R. W. Haile, A.-L. Borresen-Dale, B. S. Rosenstein, R. A. Gatti, S. N. Teraoka, A. T. Diep, L. Jansen, D. P. Atencio, B. Langholz, et al. Variants in the ATM Gene Associated with a Reduced Risk of Contralateral Breast Cancer Cancer Res., August 15, 2008; 68(16): 6486 - 6491. [Abstract] [Full Text] [PDF]

				W. Yan, G. Liu, A. Scoumanne, and X. Chen Suppression of Inhibitor of Differentiation 2, a Target of Mutant p53, Is Required for Gain-of-Function Mutations Cancer Res., August 15, 2008; 68(16): 6789 - 6796. [Abstract] [Full Text] [PDF]

				M. B. Kastan DNA Damage Responses: Mechanisms and Roles in Human Disease: 2007 G.H.A. Clowes Memorial Award Lecture Mol. Cancer Res., April 1, 2008; 6(4): 517 - 524. [Abstract] [Full Text] [PDF]